NDC 51079-903

Loxapine

Loxapine

Loxapine is a Oral Capsule in the Human Prescription Drug category. It is labeled and distributed by Mylan Institutional Inc.. The primary component is Loxapine Succinate.

Product ID51079-903_7cd92e8c-b4e0-1c1f-e053-2a91aa0a13df
NDC51079-903
Product TypeHuman Prescription Drug
Proprietary NameLoxapine
Generic NameLoxapine
Dosage FormCapsule
Route of AdministrationORAL
Marketing Start Date2004-12-15
Marketing CategoryANDA / ANDA
Application NumberANDA076762
Labeler NameMylan Institutional Inc.
Substance NameLOXAPINE SUCCINATE
Active Ingredient Strength50 mg/1
NDC Exclude FlagN
Listing Certified Through2019-12-31

Packaging

NDC 51079-903-20

100 BLISTER PACK in 1 CARTON (51079-903-20) > 1 CAPSULE in 1 BLISTER PACK (51079-903-01)
Marketing Start Date2004-12-15
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 51079-903-01 [51079090301]

Loxapine CAPSULE
Marketing CategoryANDA
Application NumberANDA076762
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2004-12-15
Marketing End Date2019-09-30

NDC 51079-903-20 [51079090320]

Loxapine CAPSULE
Marketing CategoryANDA
Application NumberANDA076762
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2004-12-15
Marketing End Date2019-09-30

Drug Details

Active Ingredients

IngredientStrength
LOXAPINE SUCCINATE50 mg/1

OpenFDA Data

SPL SET ID:0c0a9ed3-20c8-48c2-bc18-8b0b4260e300
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 314075
  • 311385
  • 314078

    • Medicade Reported Pricing

    51079090320 LOXAPINE 50 MG CAPSULE

    Pricing Unit: EA | Drug Type:

    51079090301 LOXAPINE 50 MG CAPSULE

    Pricing Unit: EA | Drug Type: